摘要
近期,美国心脏协会(American Heart Association,AHA)、美国心脏病学会(American College of Cardiology,ACC)等六大学会联合发布了《2023 AHA/ACC/ACCP/ASPC/NLA/PCNA慢性冠状动脉疾病患者管理指南》,该指南强调了“以患者为中心,以团队为基础”的总体管理理念和重视生活方式改善对慢性冠状动脉疾病患者预后的影响,并对主要心血管不良事件风险评估及新型药物推荐等作出了新的阐述,指南内容的更新对于指导我国临床医生为慢性冠状动脉疾病患者提供高质量管理具有重要指导意义。
In July 2023,the American Heart Association(AHA),the American College of Cardiology(ACC),and four other professional societies jointly released the updated version of the AHA/ACC/ACCP/ASPC/NLA/PCNA Guidelines for the Management of Patients with Chronic Coronary Artery Disease.This guide⁃line emphasizes a patient⁃centered and team⁃based approach to the overall management of chronic coronary artery disease(CCD),highlights the impact of lifestyle improvements on the prognosis of CCD patients,and provides new insights into risk assessment for major adverse cardiovascular events(MACE)and recommenda⁃tions for novel medications.These updates hold significant guiding value for health care professionals in China to provide high⁃quality management for CCD patients.
作者
梁岩
LIANG Yan(Department of Critical Care Medicine,Fuwai Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,National Center for Cardiovascular Diseases,Beijing 100037,China)
出处
《协和医学杂志》
CSCD
北大核心
2024年第2期312-319,共8页
Medical Journal of Peking Union Medical College Hospital
基金
国家重点研发计划(2023YFC2413001)。
关键词
慢性冠状动脉疾病
诊断
治疗
管理
指南
chronic coronary artery disease
diagnosis
treatment
management
guidelines
